Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysisRoberta Caputo, Michelino De Laurentiis, Giuseppe Buono et al.|Frontiers in Oncology|2024Cited by 74
Targeting a Specific Glycosylated Epitope of CD43 with a New Humanized Monoclonal Antibody for the Treatment of Pediatric and Adult T-Cell Acute Lymphoblastic Leukemia (T-ALL)Cirino Botta, Pierfrancesco Tassone, Katia Grillone et al.|Blood|2018Cited by 1
354P Sacituzumab govitecan for the treatment of metastatic triple-negative breast cancer patients: A multicenter real-world updated analysisR. Caputo, Michelino De Laurentiis, Michela Piezzo et al.|ESMO Open|2025Cited by 1